Add like
Add dislike
Add to saved papers

Morton's Neuroma (Interdigital Neuralgia) Treated with Metatarsal Sliding Osteotomy.

Background: Morton's neuroma is a common cause of metatarsalgia and many treatments had been described in literature. However, there have been only a few reports that treat the neuroma with an osteotomy on the proximal, not distal portion of the metatarsal bone using a plate. This study describes the clinical outcome of sliding osteotomy on the proximal metatarsal bone for the treatment of Morton's neuroma.

Materials and Methods: Sixty five consecutive patients (85 feet) who underwent surgery for Morton's neuroma between November 2010 and February 2013 were identified from hospital records to include in this retrospective study. Average followup period was 37.3 months (range 24-51 months). Mean patient age at surgery was 50.2 years (range 23-75 years). Metatarsal sliding osteotomies were only performed on the third metatarsal bone. Clinical evaluations with the American Orthopaedic Foot and Ankle Society Lesser Metatarsophalangeal Interphalangeal Scale (AOFAS LMIS) and Foot Function Index (FFI) were performed. The length of the lesser toe was measured for radiologic evaluation.

Results: Postoperatively, AOFAS LMIS and FFI were improved from 52.1 (range 45-60) and 62.4 (range 54-73) to 74.2 (range 68-86) and 31.3 (range 26-37). At the last followup, preoperative pain was dissolved in 79 feet (93% of overall 85 feet). A shortened 3.2 mm (±1.1) metatarsal bone following osteotomy was radiographically measured. There were six cases of complications (soft tissue infection, early numbness, delayed union, limitation of dorsiflexion and metal failure, etc.).

Conclusions: This proximal metatarsal sliding osteotomy can be a relatively effective operative method in relieving pain from Morton's neuroma.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app